Clinical trials
Carcinoma, Non-Small-Cell Lung trials in Switzerland
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
173 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 3 |
| 2002 | 1 |
| 2003 | 2 |
| 2004 | 3 |
| 2005 | 6 |
| 2006 | 2 |
| 2007 | 6 |
| 2008 | 5 |
| 2009 | 3 |
| 2010 | 5 |
| 2011 | 2 |
| 2012 | 3 |
| 2013 | 3 |
| 2014 | 9 |
| 2015 | 10 |
| 2016 | 6 |
| 2017 | 9 |
| 2018 | 7 |
| 2019 | 7 |
| 2020 | 13 |
| 2021 | 8 |
| 2022 | 10 |
| 2023 | 11 |
| 2024 | 9 |
| 2025 | 15 |
| 2026 | 7 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 75 |
| Recruiting | 36 |
| Terminated | 25 |
| Active, not recruiting | 23 |
| Unknown status | 8 |
| Withdrawn | 3 |
| Not yet recruiting | 1 |
| Available | 1 |
| Approved for marketing | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Swiss Cancer Institute | 17 |
| Hoffmann-La Roche | 14 |
| ETOP IBCSG Partners Foundation | 12 |
| Bristol-Myers Squibb | 11 |
| Novartis Pharmaceuticals | 10 |
| AstraZeneca | 8 |
| Pfizer | 8 |
| Eli Lilly and Company | 6 |
| European Organisation for Research and Treatment of Cancer - EORTC | 6 |
| Amgen | 4 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Non-Small-Cell Lung | 173 |
| Lung Neoplasms | 44 |
| Neoplasms | 19 |
| Melanoma | 14 |
| Breast Neoplasms | 11 |
| Neoplasm Metastasis | 11 |
| Adenocarcinoma of Lung | 8 |
| Carcinoma, Renal Cell | 8 |
| Ovarian Neoplasms | 8 |
| Carcinoma | 7 |
Trials
Showing 51 to 75 of 173. Each trial links to its page on Pharma Observatory.
73 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.